Amanta Healthcare Limited has scheduled a Board of Directors meeting for Wednesday, August 5, 2026. The primary agenda is to consider and approve the company's Unaudited Financial Results for the quarter ended June 30, 2026 (Q1 FY27).
The company confirms compliance with SEBI's insider trading regulations regarding the trading window closure. The trading window was previously closed effective Wednesday, July 1, 2026, as intimated in the company's earlier communication dated June 27, 2026. The trading window will reopen on Saturday, August 8, 2026, following the results announcement.
The disclosure is made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and has been submitted to both BSE Limited and National Stock Exchange of India Limited.
The communication is digitally signed by Dinodia Nikhita, who holds the position of Company Secretary at Amanta Healthcare Limited. The company's Corporate Identification Number (CIN) is L24139GJ1994PLC023944.